substance p has been researched along with ramiprilat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lloyd, GS; Turner, AJ | 1 |
| Carretero, OA; Curran, CM; Hintze, TH; Laycock, SK; Loke, KE; Messina, EJ; Shesely, EG | 1 |
| Hintze, TH; Kaley, G; Loke, KE; Messina, EJ; Shesely, EG | 1 |
3 other study(ies) available for substance p and ramiprilat
| Article | Year |
|---|---|
Aminopeptidase P: cation activation and inhibitor sensitivity are substrate-dependent.
Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cilazapril; Enalaprilat; Kidney; Kinetics; Molecular Sequence Data; Oligopeptides; Ramipril; Substance P; Substrate Specificity; Swine | 1995 |
Role of nitric oxide in the control of cardiac oxygen consumption in B(2)-kinin receptor knockout mice.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium Channel Blockers; Drug Interactions; Enzyme Inhibitors; Female; Heart; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen Consumption; Ramipril; Receptors, Bradykinin; Substance P | 1999 |
Potential role of eNOS in the therapeutic control of myocardial oxygen consumption by ACE inhibitors and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Culture Techniques; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen Consumption; Ramipril; S-Nitroso-N-Acetylpenicillamine; Substance P; Vasodilator Agents | 2001 |